Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.8, 2013-08, pp. : 869-871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 841-863

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting VEGF in lung cancer

By Das Millie Wakelee Heather

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 395-406

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy for Metastatic Colorectal Cancer

By Rosales Joseph Leong Lucille A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 4, 2005-07 ,pp. : 525-529

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Panitumumab: In the Treatment of Metastatic Colorectal Cancer

By Hoy Sheridan M. Wagstaff Antona J.

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 2005-2014

Adis International

Access to resources Recommend Favorite

FOLFOXIRI promising in metastatic colorectal cancer

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite